VX5
Gecertificeerd

VX5

Catalog #: HY-P991567-01
Maat: 1 mg
Droogijs Vereist

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

VX5 is a humanized IgG1κ monoclonal antibody inhibitor targeting BCA-1/CXCL13. VX5 significantly inhibits human CXCL13-mediated internalization of CXCR5, blocks both human and mouse CXCL13-dependent B-cells chemotaxis and migration (EC50s for 105 and 253 nM for human tonsillar and pre-B-697-hCXCR5 cells, respectively) . VX5 can be used to study autoimmune diseases like multiple sclerosis and arthritis, and cancers like gastric lymphomas and colon cancer[1].

Product Name Alternative

VX5/5261

UNSPSC

12352203

Target

CXCR

Related Pathways

GPCR/G Protein; Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Inflammation/Immunology

Purity

96.19

References & Citations

[1]Klimatcheva E, et al. Anti-cxcl13 antibodies and associated epitope sequences. US20160002325A1. 2016-01-07.

Shipping Conditions

Dry Ice

Storage Conditions

-80°C

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-P991567/VX5-SDS-MedChemExpress.pdf

Scientific Category

Inhibitory Antibodies

Clinical Information

No Development Reported

Beschrijving

VX5 is a humanized IgG1κ monoclonal antibody inhibitor targeting BCA-1/CXCL13. VX5 significantly inhibits human CXCL13-mediated internalization of CXCR5, blocks

Specificaties

ProductnaamVX5
Categorie
Beschikbare grootte1 mg
CatalogusnummerHY-P991567-01